Transmedics Group Inc
(TMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 441,540 | 241,623 | 93,459 | 30,262 | 25,639 |
| Cost of Goods | 179,459 | 87,530 | 28,187 | 9,103 | 9,004 |
| Gross Profit | 262,081 | 154,093 | 65,272 | 21,159 | 16,635 |
| Operating Expenses | 225,044 | 183,350 | 96,896 | 60,690 | 43,023 |
| Operating Income | 37,496 | -28,727 | -31,437 | -39,428 | -26,384 |
| Interest Expense | 14,409 | 10,791 | 3,726 | 3,874 | 3,985 |
| Other Income | 12,693 | 12,847 | -1,002 | -877 | 1,653 |
| Pre-tax Income | 35,780 | -26,671 | -36,165 | -44,179 | -28,716 |
| Income Tax | 316 | -1,643 | 66 | 36 | 32 |
| Net Income Continuous | 35,464 | -25,028 | -36,231 | -44,215 | -28,748 |
| Net Income | $35,464 | $-25,028 | $-36,231 | $-44,215 | $-28,748 |
| EPS Basic Total Ops | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 |
| EPS Basic Continuous Ops | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 |
| EPS Diluted Total Ops | 1.01 | -0.77 | -1.23 | -1.60 | -1.16 |
| EPS Diluted Continuous Ops | 1.01 | -0.77 | -1.23 | -1.60 | -1.16 |
| EPS Diluted Before Non-Recurring Items | 1.01 | -0.11 | -1.23 | -1.60 | -1.16 |
| EBITDA(a) | $57,254 | $-20,550 | $-27,959 | $-37,611 | $-24,807 |